loading
Schlusskurs vom Vortag:
$1.55
Offen:
$1.53
24-Stunden-Volumen:
297.72K
Relative Volume:
0.37
Marktkapitalisierung:
$46.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-42.37M
KGV:
-1.4037
EPS:
-1.0686
Netto-Cashflow:
$-34.94M
1W Leistung:
-6.83%
1M Leistung:
-68.42%
6M Leistung:
-33.04%
1J Leistung:
-73.02%
1-Tages-Spanne:
Value
$1.48
$1.56
1-Wochen-Bereich:
Value
$1.47
$1.64
52-Wochen-Spanne:
Value
$1.14
$5.96

Skye Bioscience Inc Stock (SKYE) Company Profile

Name
Firmenname
Skye Bioscience Inc
Name
Telefon
(858) 410-0266
Name
Adresse
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO
Name
Mitarbeiter
16
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
SKYE's Discussions on Twitter

Vergleichen Sie SKYE mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
 icon
SKYE
Skye Bioscience Inc.
3.10 12.89M 0 0 0 0.00
 icon
MOBBW
Mobilicom Limited Warrants
3.17 4.40B 0 0 0 0.00
 icon
GOODO
Gladstone Commercial Corporation
19.96 372.90M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
5.05 189.47M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.237 554.19M 2.07B -1.42B -1.37B -0.6765
 icon
DAVEW
Dave Inc
1.40 0 0 0 0 0.00

Skye Bioscience Inc Stock (SKYE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-06 Herabstufung Cantor Fitzgerald Overweight → Neutral
2025-10-06 Herabstufung Craig Hallum Buy → Hold
2025-08-15 Eingeleitet Evercore ISI Outperform
2025-02-28 Eingeleitet William Blair Outperform
2024-09-30 Eingeleitet Scotiabank Sector Outperform
2024-09-10 Eingeleitet JMP Securities Mkt Outperform
2024-07-09 Eingeleitet Craig Hallum Buy
2024-05-23 Eingeleitet Cantor Fitzgerald Overweight
2024-04-12 Eingeleitet Oppenheimer Outperform
Alle ansehen

Skye Bioscience Inc Aktie (SKYE) Neueste Nachrichten

pulisher
01:13 AM

Applying big data sentiment scoring on Skye Bioscience Inc.July 2025 Volume & Expert Approved Momentum Ideas - newser.com

01:13 AM
pulisher
Nov 03, 2025

Price action breakdown for Skye Bioscience Inc.GDP Growth & Weekly High Conviction Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Live market analysis of Skye Bioscience Inc.Weekly Profit Summary & Weekly High Conviction Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Skye Bioscience Inc. (09R) stock a momentum leaderJuly 2025 Sector Moves & AI Enhanced Trading Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Skye Bioscience Inc. stock a defensive play in 2025Weekly Risk Report & Growth-Oriented Investment Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How to integrate Skye Bioscience Inc. into portfolio analysis toolsProfit Target & AI Enhanced Trading Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Skye Bioscience Inc. (09R) stock outperform foreign stocksJuly 2025 Opening Moves & Weekly Momentum Stock Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Skye Bioscience Inc. stock go up soon2025 Geopolitical Influence & Expert-Curated Trade Recommendations - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why Skye Bioscience Inc. stock appeals to dividend seekersQuarterly Earnings Report & Expert Curated Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Skye Bioscience Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView

Nov 03, 2025
pulisher
Nov 03, 2025

Is Skye Bioscience Inc. forming a reversal patternInsider Selling & Weekly Return Optimization Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Skye Bioscience Inc. still worth holding after the dipJuly 2025 Setups & Daily Stock Trend Watchlist - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Volatility clustering patterns for Skye Bioscience Inc.Trade Exit Report & Safe Entry Zone Identification - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Skye Bioscience Inc. stock reacts to inflationary pressuresMarket Weekly Review & Momentum Based Trading Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can Skye Bioscience Inc. stock maintain growth trajectoryBuy Signal & Fast Exit/Entry Strategy Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What technical models suggest about Skye Bioscience Inc.’s comeback - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Skye Bioscience Inc. stock performs in weak economyFed Meeting & Daily Growth Stock Tips - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Intraday pattern recognizer results for Skye Bioscience Inc.GDP Growth & Weekly Market Pulse Updates - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will Skye Bioscience Inc. (09R) stock keep raising dividendsJuly 2025 EndofMonth & Community Consensus Stock Picks - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Is Skye Bioscience Inc a good long term investmentCapital Gains Strategies & Rapid Portfolio Investment - earlytimes.in

Nov 01, 2025
pulisher
Nov 01, 2025

Regression analysis insights on Skye Bioscience Inc. performanceGDP Growth & Weekly Market Pulse Alerts - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

What analysts say about Skye Bioscience Inc stockSupport Zone Identification & Ride the Trends That Billionaires Follow - earlytimes.in

Oct 31, 2025
pulisher
Oct 31, 2025

Will Skye Bioscience Inc. stock deliver consistent dividendsGold Moves & Fast Exit and Entry Strategy Plans - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How Skye Bioscience Inc. stock performs during Fed tightening cyclesRate Hike & Weekly Setup with ROI Potential - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-30 23:45:10 - newser.com

Oct 31, 2025

Finanzdaten der Skye Bioscience Inc-Aktie (SKYE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Skye Bioscience Inc-Aktie (SKYE) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Schwab Andrew J.
Director
Aug 21 '25
Sale
3.57
60,956
217,613
63,963
5AM Partners VII, LLC
10% Owner
Aug 22 '25
Sale
3.42
170,449
582,936
57,493
5AM Partners VII, LLC
10% Owner
Aug 21 '25
Sale
3.57
60,956
217,613
63,963
Diep Tuan Tu
Chief Development Officer
Nov 18 '24
Sale
4.99
19,489
97,250
82,259
Diep Tuan Tu
Chief Development Officer
Nov 15 '24
Sale
5.55
85
472
101,748
ARSENAULT KAITLYN
Chief Financial Officer
Nov 18 '24
Sale
4.99
43,206
215,598
166,342
ARSENAULT KAITLYN
Chief Financial Officer
Nov 15 '24
Sale
5.55
190
1,054
209,548
DHILLON PUNIT
Chief Executive Officer
Nov 18 '24
Sale
4.99
82,546
411,905
329,823
DHILLON PUNIT
Chief Executive Officer
Nov 15 '24
Sale
5.55
364
2,020
412,369
Grayson Paul A.
Director
Nov 18 '24
Sale
4.99
86,244
430,358
259,701
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):